Updated: May 18, 2026

Paul Eckburg

ANTXAN2 Therapeutics, Inc.SEC CIK: 0001914512
Estimated Net Worth
$107 Thousand
Last Updated: May 18, 2026 07:38 PM EST

Transaction Summary

Total Transactions5
Buy-Sell Ratio
Buy Transactions0
Sell Transactions0

Transaction Volume

Total Volume$0.00
Net Volume$0.00
Buy Volume$0.00
Sell Volume$0.00

Trade Analysis

AVG Trade Size$0.00
Largest Trade$0.00
Most Active MonthMar
Most Active Year2024

Trading Sentiment

OverallNeutral
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Paul Eckburg does not have any significant net worth to report based on the numbers we have. This is based on reported shares in AN2 Therapeutics, Inc..



2024 was Paul Eckburg's most active year for acquiring shares with 3 total transactions. Paul Eckburg's most active month to acquire stocks was the month of February. 2023 saw Paul Eckburg paying a total of $0.00 for 70,950 shares, this is the most they've acquired in one year.

Holdings & Transactions

ANTXan2 therapeutics, inc.
Chief Medical Officer
Updated: Mar 29, 2024VIEW QUOTE
Form TypeSEC Filing
1.4030.00K51.42KMar 15View
4.2090.00K111.42KMar 15View
70.95K70.95KFeb 15View
66.00K66.00KMay 12View
18.29KView